APO RESEARCH · REPORT
Medical Grade Chitosan
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Product & engineering
Understand the product.
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Selected research
Industry Growth & Trends
Global Medical Grade Chitosan Industry Growth and Trends Forecast to 2032
Market perspective
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Medical Grade Chitosan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Grade Chitosan market size, estimates, and forecasts are presented in terms of sales volume (Ton) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Grade Chitosan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Grade Chitosan.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Medical Grade Chitosan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Grade Chitosan Market by Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Medical Grade Chitosan Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Medical Grade Chitosan Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
Medical Grade Chitosan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Grade Chitosan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Grade Chitosan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Grade Chitosan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Grade Chitosan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Medical Grade Chitosan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Origin Chitosan
- Plant Based Chitosan
Applications
- Wound Care
- Healthcare Products
- Antibacterial Products
- Others
Companies covered
- Primex
- KitoZyme
- BIO21
- YSK
- Vietnam Food
- NovaMatrix
- KIMICA
- Ningbo Zhenhai Haixin Biological
- Golden-Shell Pharmaceutical
- Zhejiang Fengrun Biotech
- Jiangsu Shuanglin
- Jiangsu Aoxin Biotechnology
- Qingdao Yunzhou Biochemistry
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Grade Chitosan Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Grade Chitosan Sales Estimates and Forecasts (2021-2032)
- 1.3 Medical Grade Chitosan Market by Type
- 1.3.1 Animal Origin Chitosan
- 1.3.2 Plant Based Chitosan
- 1.4 Global Medical Grade Chitosan Market Size by Type
- 1.4.1 Global Medical Grade Chitosan Market Size Overview by Type (2021-2032)
- 1.4.2 Global Medical Grade Chitosan Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Medical Grade Chitosan Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Medical Grade Chitosan Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Medical Grade Chitosan Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Medical Grade Chitosan Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Medical Grade Chitosan Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Medical Grade Chitosan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Medical Grade Chitosan Industry Trends
- 2.2 Medical Grade Chitosan Industry Drivers
- 2.3 Medical Grade Chitosan Industry Opportunities and Challenges
- 2.4 Medical Grade Chitosan Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Medical Grade Chitosan Revenue (2021-2026)
- 3.2 Global Top Players by Medical Grade Chitosan Sales (2021-2026)
- 3.3 Global Top Players by Medical Grade Chitosan Price (2021-2026)
- 3.4 Global Medical Grade Chitosan Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Grade Chitosan Major Company Production Sites & Headquarters
- 3.6 Global Medical Grade Chitosan Company, Product Type & Application
- 3.7 Global Medical Grade Chitosan Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Grade Chitosan Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Grade Chitosan Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Grade Chitosan Tier 1, Tier 2, and Tier 3
4 Medical Grade Chitosan Regional Status and Outlook
- 4.1 Global Medical Grade Chitosan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Medical Grade Chitosan Historic Market Size by Region
- 4.2.1 Global Medical Grade Chitosan Sales in Volume by Region (2021-2026)
- 4.2.2 Global Medical Grade Chitosan Sales in Value by Region (2021-2026)
- 4.2.3 Global Medical Grade Chitosan Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Medical Grade Chitosan Forecasted Market Size by Region
- 4.3.1 Global Medical Grade Chitosan Sales in Volume by Region (2027-2032)
- 4.3.2 Global Medical Grade Chitosan Sales in Value by Region (2027-2032)
- 4.3.3 Global Medical Grade Chitosan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Grade Chitosan by Application
- 5.1 Medical Grade Chitosan Market by Application
- 5.1.1 Wound Care
- 5.1.2 Healthcare Products
- 5.1.3 Antibacterial Products
- 5.1.4 Others
- 5.2 Global Medical Grade Chitosan Market Size by Application
- 5.2.1 Global Medical Grade Chitosan Market Size Overview by Application (2021-2032)
- 5.2.2 Global Medical Grade Chitosan Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Medical Grade Chitosan Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Medical Grade Chitosan Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Medical Grade Chitosan Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Medical Grade Chitosan Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Medical Grade Chitosan Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Medical Grade Chitosan Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Primex
- 6.1.1 Primex Company Information
- 6.1.2 Primex Business Overview
- 6.1.3 Primex Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Primex Medical Grade Chitosan Product Portfolio
- 6.1.5 Primex Recent Developments
- 6.2 KitoZyme
- 6.2.1 KitoZyme Company Information
- 6.2.2 KitoZyme Business Overview
- 6.2.3 KitoZyme Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 KitoZyme Medical Grade Chitosan Product Portfolio
- 6.2.5 KitoZyme Recent Developments
- 6.3 BIO21
- 6.3.1 BIO21 Company Information
- 6.3.2 BIO21 Business Overview
- 6.3.3 BIO21 Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 BIO21 Medical Grade Chitosan Product Portfolio
- 6.3.5 BIO21 Recent Developments
- 6.4 YSK
- 6.4.1 YSK Company Information
- 6.4.2 YSK Business Overview
- 6.4.3 YSK Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 YSK Medical Grade Chitosan Product Portfolio
- 6.4.5 YSK Recent Developments
- 6.5 Vietnam Food
- 6.5.1 Vietnam Food Company Information
- 6.5.2 Vietnam Food Business Overview
- 6.5.3 Vietnam Food Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Vietnam Food Medical Grade Chitosan Product Portfolio
- 6.5.5 Vietnam Food Recent Developments
- 6.6 NovaMatrix
- 6.6.1 NovaMatrix Company Information
- 6.6.2 NovaMatrix Business Overview
- 6.6.3 NovaMatrix Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 NovaMatrix Medical Grade Chitosan Product Portfolio
- 6.6.5 NovaMatrix Recent Developments
- 6.7 KIMICA
- 6.7.1 KIMICA Company Information
- 6.7.2 KIMICA Business Overview
- 6.7.3 KIMICA Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 KIMICA Medical Grade Chitosan Product Portfolio
- 6.7.5 KIMICA Recent Developments
- 6.8 Ningbo Zhenhai Haixin Biological
- 6.8.1 Ningbo Zhenhai Haixin Biological Company Information
- 6.8.2 Ningbo Zhenhai Haixin Biological Business Overview
- 6.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product Portfolio
- 6.8.5 Ningbo Zhenhai Haixin Biological Recent Developments
- 6.9 Golden-Shell Pharmaceutical
- 6.9.1 Golden-Shell Pharmaceutical Company Information
- 6.9.2 Golden-Shell Pharmaceutical Business Overview
- 6.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Product Portfolio
- 6.9.5 Golden-Shell Pharmaceutical Recent Developments
- 6.10 Zhejiang Fengrun Biotech
- 6.10.1 Zhejiang Fengrun Biotech Company Information
- 6.10.2 Zhejiang Fengrun Biotech Business Overview
- 6.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Product Portfolio
- 6.10.5 Zhejiang Fengrun Biotech Recent Developments
- 6.11 Jiangsu Shuanglin
- 6.11.1 Jiangsu Shuanglin Company Information
- 6.11.2 Jiangsu Shuanglin Business Overview
- 6.11.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Jiangsu Shuanglin Medical Grade Chitosan Product Portfolio
- 6.11.5 Jiangsu Shuanglin Recent Developments
- 6.12 Jiangsu Aoxin Biotechnology
- 6.12.1 Jiangsu Aoxin Biotechnology Company Information
- 6.12.2 Jiangsu Aoxin Biotechnology Business Overview
- 6.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Portfolio
- 6.12.5 Jiangsu Aoxin Biotechnology Recent Developments
- 6.13 Qingdao Yunzhou Biochemistry
- 6.13.1 Qingdao Yunzhou Biochemistry Company Information
- 6.13.2 Qingdao Yunzhou Biochemistry Business Overview
- 6.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Portfolio
- 6.13.5 Qingdao Yunzhou Biochemistry Recent Developments
7 North America by Country
- 7.1 North America Medical Grade Chitosan Sales by Country
- 7.1.1 North America Medical Grade Chitosan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Medical Grade Chitosan Sales by Country (2021-2026)
- 7.1.3 North America Medical Grade Chitosan Sales Forecast by Country (2027-2032)
- 7.2 North America Medical Grade Chitosan Market Size by Country
- 7.2.1 North America Medical Grade Chitosan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Medical Grade Chitosan Market Size by Country (2021-2026)
- 7.2.3 North America Medical Grade Chitosan Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Medical Grade Chitosan Sales by Country
- 8.1.1 Europe Medical Grade Chitosan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Medical Grade Chitosan Sales by Country (2021-2026)
- 8.1.3 Europe Medical Grade Chitosan Sales Forecast by Country (2027-2032)
- 8.2 Europe Medical Grade Chitosan Market Size by Country
- 8.2.1 Europe Medical Grade Chitosan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Medical Grade Chitosan Market Size by Country (2021-2026)
- 8.2.3 Europe Medical Grade Chitosan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Medical Grade Chitosan Sales by Country
- 9.1.1 Asia-Pacific Medical Grade Chitosan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Medical Grade Chitosan Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Medical Grade Chitosan Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Medical Grade Chitosan Market Size by Country
- 9.2.1 Asia-Pacific Medical Grade Chitosan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Medical Grade Chitosan Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Medical Grade Chitosan Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Medical Grade Chitosan Sales by Country
- 10.1.1 South America Medical Grade Chitosan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Medical Grade Chitosan Sales by Country (2021-2026)
- 10.1.3 South America Medical Grade Chitosan Sales Forecast by Country (2027-2032)
- 10.2 South America Medical Grade Chitosan Market Size by Country
- 10.2.1 South America Medical Grade Chitosan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Medical Grade Chitosan Market Size by Country (2021-2026)
- 10.2.3 South America Medical Grade Chitosan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Medical Grade Chitosan Sales by Country
- 11.1.1 Middle East and Africa Medical Grade Chitosan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Medical Grade Chitosan Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Medical Grade Chitosan Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Medical Grade Chitosan Market Size by Country
- 11.2.1 Middle East and Africa Medical Grade Chitosan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Medical Grade Chitosan Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Medical Grade Chitosan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Medical Grade Chitosan Value Chain Analysis
- 12.1.1 Medical Grade Chitosan Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Medical Grade Chitosan Production Mode & Process
- 12.2 Medical Grade Chitosan Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Medical Grade Chitosan Distributors
- 12.2.3 Medical Grade Chitosan Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst